Thomas Desrosier has an estimated net worth of $3.76 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Seres Therapeutics, Inc., ARIAD PHARMACEUTICALS INC, and CUBIST PHARMACEUTICALS INC.
2014 was Thomas Desrosier's most active year for acquiring shares with 11 total transactions. Thomas Desrosier's most active month to acquire stocks was the month of January. 2011 was Thomas Desrosier's most active year for disposing of shares, totalling 17 transactions. Thomas Desrosier's most active month to dispose stocks was the month of March. 2010 saw Thomas Desrosier paying a total of $1,186,917.76 for 28,871 shares, this is the most they've acquired in one year. In 2011 Thomas Desrosier cashed out on 224,430 shares for a total of $12,333,384.76, their largest year based on trade value.